| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...9210663N |
| P356 | DOI | 10.1073/PNAS.92.23.10663 |
| P932 | PMC publication ID | 40672 |
| P698 | PubMed publication ID | 7479861 |
| P5875 | ResearchGate publication ID | 15718962 |
| P2093 | author name string | L Zhang | |
| M Nakajima | |||
| M Horiuchi | |||
| R Morishita | |||
| V J Dzau | |||
| R E Pratt | |||
| W Hayashida | |||
| M Fujinaga | |||
| H G Hutchinson | |||
| P2860 | cites work | Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury | Q28567380 |
| Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors | Q28646037 | ||
| Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition | Q28646038 | ||
| Novel and effective gene transfer technique for study of vascular renin angiotensin system | Q30449287 | ||
| Expression of AT2 receptors in the developing rat fetus | Q34198676 | ||
| Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor | Q36758429 | ||
| Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development | Q37649847 | ||
| The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells | Q38299038 | ||
| Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction | Q40341321 | ||
| Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues | Q41900707 | ||
| Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method | Q41999020 | ||
| Identification of angiotensin II receptor subtypes | Q42191856 | ||
| Biochemical Properties of the Ovarian Granulosa Cell Type 2-Angiotensin II Receptor* | Q42471014 | ||
| Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries | Q43758575 | ||
| Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall | Q44193259 | ||
| Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices | Q44331620 | ||
| Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing | Q45073640 | ||
| Changes in expression of angiotensin receptor subtypes in the rat aorta during development. | Q52048484 | ||
| Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. | Q52218458 | ||
| Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells | Q57630630 | ||
| Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty | Q67669988 | ||
| Increased expression of DNA cointroduced with nuclear protein in adult rat liver | Q69937795 | ||
| Significance of quiescent smooth muscle migration in the injured rat carotid artery | Q70049140 | ||
| Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II | Q70744714 | ||
| Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation | Q72080810 | ||
| Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells | Q72082538 | ||
| Involvement of protein kianse C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts | Q72850318 | ||
| Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury | Q93514193 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10663-10667 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer | |
| P478 | volume | 92 |
| Q61443913 | A Series of Analogues to the ATR Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode |
| Q35099138 | A local pancreatic renin-angiotensin system: endocrine and exocrine roles |
| Q48667990 | A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q37531017 | AT(2) receptor and tissue injury: therapeutic implications |
| Q44070694 | AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. |
| Q35925706 | AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction |
| Q90068098 | AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis |
| Q77937510 | AT2 receptor stimulation induces generation of ceramides in PC12W cells |
| Q41819451 | AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation |
| Q45199006 | AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats. |
| Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
| Q39117200 | Activating types 1 and 2 angiotensin II receptors modulate the hypertrophic differentiation of chondrocytes |
| Q74510339 | Activation of p42/p44 mitogen-activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2alpha in hepatocytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin-sensitive |
| Q34238307 | Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation |
| Q38328643 | An A/T-rich cis-element is essential for rat angiotensin II type 1A receptor transcription in vascular smooth muscle cells |
| Q22010261 | Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis |
| Q73689200 | Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins |
| Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
| Q42518248 | Angiotensin II AT(2) receptor inhibits smooth muscle cell migration via fibronectin cell production and binding |
| Q40791969 | Angiotensin II AT(2) receptors inhibit growth responses in proximal tubule cells |
| Q28577645 | Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor |
| Q33718262 | Angiotensin II and connective tissue: homeostasis and reciprocal regulation |
| Q33605952 | Angiotensin II and extracellular matrix homeostasis. |
| Q48311566 | Angiotensin II in central nervous system physiology |
| Q52165014 | Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney. |
| Q64121994 | Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress |
| Q38167346 | Angiotensin II receptor antagonists in acute coronary syndromes |
| Q46165787 | Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression |
| Q34496676 | Angiotensin II receptors and drug discovery in cardiovascular disease |
| Q42155832 | Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium |
| Q77687808 | Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells |
| Q35855619 | Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall |
| Q73832450 | Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist |
| Q42378890 | Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium |
| Q37986143 | Angiotensin II type 2 receptor agonists: where should they be applied? |
| Q37622578 | Angiotensin II type 2 receptor gene polymorphisms in cardiovascular disease |
| Q28272739 | Angiotensin II type 2 receptor mediates programmed cell death |
| Q40851849 | Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation |
| Q42987208 | Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase |
| Q41087331 | Angiotensin II type-2 (AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells |
| Q41701250 | Angiotensin II type-I receptor antagonists in the treatment of heart failure |
| Q34555180 | Angiotensin II-mediated signal transduction pathways. |
| Q77943856 | Angiotensin II: a reproductive hormone too? |
| Q35122620 | Angiotensin Type 2 Receptor (AT2R): A Challenging Twin |
| Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
| Q28251955 | Angiotensin antagonism in coronary artery disease: results after coronary revascularisation |
| Q35857462 | Angiotensin peptides and lung cancer |
| Q36697565 | Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects |
| Q34283096 | Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure |
| Q34117865 | Angiotensin receptors--evolutionary overview and perspectives |
| Q38275879 | Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects |
| Q24324656 | Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients |
| Q34248966 | Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration |
| Q38193206 | Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling |
| Q46896298 | Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor |
| Q28362086 | Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis |
| Q42078470 | Apoptosis after reperfused myocardial infarction: Role of angiotensin II. |
| Q36489750 | Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway |
| Q35838481 | Are angiotensin receptor blockers neuroprotective? |
| Q51768918 | Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. |
| Q84356902 | Association of polymorphisms in angiotensin II receptor genes with aldosterone-producing adenoma |
| Q36145170 | Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease |
| Q54586666 | Both AT₁ and AT₂ receptors mediate proliferation and migration of porcine vascular smooth muscle cells. |
| Q73515538 | Brain AT(2) receptor mediate vasodepressor response to footshocks: role of kinins and nitric oxide |
| Q73521642 | Cardiac angiotensin II receptors: studies on functional coupling in Sprague-Dawley rats and TGR(alphaMHC-hAT1) transgenic rats |
| Q28505671 | Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects |
| Q54610810 | Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. |
| Q83694338 | Cellular and RAS changes in the hearts of young obese rats |
| Q33551485 | Changes in the renin angiotensin system during the development of colorectal cancer liver metastases |
| Q44851212 | Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats |
| Q40611479 | Characterization of angiotensin II-receptor subtypes in podocytes |
| Q51819142 | Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. |
| Q73268079 | Contribution of bradykinin and nitric oxide to AT2 receptor‐mediated differentiation in PC12 W cells |
| Q34626518 | Deciphering the nuclear bile acid receptor FXR paradigm |
| Q54017982 | Development of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms. |
| Q36204914 | Developmental nicotine exposure results in programming of alveolar simplification and interstitial pulmonary fibrosis in adult male rats. |
| Q34078729 | Distribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brains |
| Q43762867 | Do vascular compartments differ in the development of chronic rejection? AT(1) blocker candesartan versus Ace blocker enalapril in an experimental heart transplant model |
| Q35782663 | Early expression of all the components of the renin-angiotensin-system in human development |
| Q32032127 | Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors |
| Q43518213 | Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans |
| Q73295578 | Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction |
| Q42452224 | Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells |
| Q37365932 | Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors |
| Q46916947 | Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts |
| Q46843706 | Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats |
| Q44280738 | Effects of mutations in the highly conserved DRY motif on binding affinity, expression, and G-protein recruitment of the human angiotensin II type-2 receptor. |
| Q42993543 | Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements |
| Q35218190 | Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. |
| Q60079823 | Erratum: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice |
| Q34088198 | Evolution and pathophysiology of chronic systolic heart failure |
| Q30898615 | Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study |
| Q56529178 | Expression of angiotensin II and its receptors in cyclosporine-induced gingival overgrowth |
| Q42935541 | Expression of angiotensin II receptors in aldosterone-producing adenoma of the adrenal gland and their clinical significance |
| Q48393465 | Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats |
| Q64038810 | Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression |
| Q29394497 | Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells |
| Q24563508 | Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth |
| Q37334984 | FXR an emerging therapeutic target for the treatment of atherosclerosis |
| Q46897927 | FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells |
| Q39170846 | Function and expression of ATIP and its variants in cardiomyoblast cell line H9c2. |
| Q34042721 | Genetic Association Study of Angiotensin II Receptor Types 1 (A168G) and 2 (T1247G and A5235G) Polymorphisms in Breast Carcinoma among Brazilian Women |
| Q37871869 | Genetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure |
| Q28307466 | Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome |
| Q35672941 | HIV-associated nephropathy: role of AT2R. |
| Q47279404 | Haplotypes of the angiotensin II receptor genes AGTR1 and AGTR2 in women with normotensive pregnancy and women with preeclampsia |
| Q41908818 | Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis |
| Q39686130 | Identification and characterization of CD4(+)AT2(+) T lymphocyte population in human thoracic aortic aneurysm |
| Q28138133 | Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family |
| Q44249518 | Identification of the region of AT2 receptor needed for inhibition of the AT1 receptor-mediated inositol 1,4,5-triphosphate generation |
| Q46663979 | Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. |
| Q43766131 | Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice |
| Q37138957 | Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats |
| Q47788294 | Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys |
| Q33987660 | Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q46137769 | Intracellular third loop domain of angiotensin II type-2 receptor. Role in mediating signal transduction and cellular function |
| Q52937062 | Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. |
| Q37247749 | Lessons from ONTARGET. |
| Q34731369 | Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis |
| Q73318406 | Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts |
| Q35872512 | Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia |
| Q30306044 | Mechanism of action of angiotensin-receptor blocking agents |
| Q37062099 | Mechanisms of radiation-induced brain toxicity and implications for future clinical trials |
| Q35544248 | Mechanisms of release of ATP from vascular purinergic nerves |
| Q90191397 | Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity |
| Q36748599 | Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury |
| Q52170561 | Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. |
| Q48672854 | Modulation of angiotensin II type 2 receptor mRNA in rat hypothalamus and brainstem neuronal cultures by growth factors. |
| Q41084357 | Molecular biology of angiotensin receptors and their role in human cardiovascular disease |
| Q74506097 | N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor |
| Q38206729 | New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D. |
| Q34028215 | New insights into the renin-angiotensin system and hypertensive renal disease |
| Q54584673 | No evidence for angiotensin type 2 receptor gene polymorphism in intron 1 in patients with coarctation of the aorta and Ullrich-Turner syndrome. |
| Q36137870 | Normal tissue protection for improving radiotherapy: Where are the Gaps? |
| Q30306043 | Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor |
| Q28143305 | Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors |
| Q34708939 | Obstructive uropathy: an important cause of chronic renal failure in children |
| Q30830224 | Ontogeny and regulation of the AT1 and AT2 receptors in the ovine fetal adrenal gland |
| Q49053455 | Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension |
| Q34038063 | Optimal strategies for preventing progression of renal disease: should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together? |
| Q34280097 | Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells |
| Q41082758 | Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells |
| Q36184894 | Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block |
| Q38937272 | Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells |
| Q38126111 | Pathophysiological role of the renin-angiotensin system on erectile dysfunction |
| Q43613485 | Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects |
| Q37053886 | Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment |
| Q30581028 | Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data |
| Q54361247 | Physiological regulation of extracellular matrix collagen and elastin in the arterial wall of rats by noradrenergic tone and angiotensin II. |
| Q85690746 | Platelet-endothelial cell interaction in brain microvessels of angiotensin II type-2 receptor knockout mice following transient bilateral common carotid artery occlusion |
| Q33650699 | Practical considerations of the pharmacology of angiotensin receptor blockers |
| Q35099164 | RAS and connective tissue in the heart |
| Q33593068 | Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. |
| Q36067015 | Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage |
| Q50665394 | Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. |
| Q35782695 | Renin angiotensin system in development of mice and men |
| Q43736869 | Restenotic process and DD genotype after angiotensin-converting enzyme inhibitor treatment |
| Q35791973 | Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin |
| Q39091996 | Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors |
| Q51432835 | Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. |
| Q42837409 | Role of Angiontensin Receptors on Remodeling Perivascular Nerves |
| Q48943471 | Role of Lys215 located in the fifth transmembrane domain of the AT2 receptor in ligand-receptor interaction |
| Q33883065 | Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease |
| Q53635076 | Role of angiotensin II receptor subtypes in conjunctival wound healing. |
| Q47962829 | Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves |
| Q73683748 | Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells |
| Q47998131 | Should we aim at tissue renin-angiotensin systems? |
| Q73134077 | Signaling Mechanism of the AT2 Angiotensin II Receptor: Crosstalk between AT1 and AT2 Receptors in Cell Growth |
| Q85068072 | Skeletal muscle-endothelial cell cross talk through angiotensin II |
| Q36400573 | Small-molecule AT2 receptor agonists |
| Q34970370 | Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade |
| Q46495851 | Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR. |
| Q40373896 | Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling |
| Q28281919 | The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus |
| Q33680652 | The AT2 receptor: fact, fancy and fantasy |
| Q36404036 | The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats |
| Q30413945 | The angiotensin II type 2 receptor and the kidney |
| Q37622575 | The angiotensin II type 2 receptor in cardiovascular disease |
| Q33933167 | The biochemical and physiological characteristics of receptors |
| Q39971704 | The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation |
| Q45190313 | The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep |
| Q38332834 | The increase in angiotensin type-2 receptor mRNA level by glutamate stimulation in cultured rat cortical cells |
| Q40853213 | The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice |
| Q48750342 | The renin-angiotensin system in cardiovascular diseases |
| Q34513169 | The renin-angiotensin-aldosterone system and vascular remodeling |
| Q41386967 | The role of angiotensin receptors in cardiovascular diseases |
| Q35859753 | The role of perivascular adipose tissue in vascular smooth muscle cell growth. |
| Q34522515 | The role of the renin-angiotensin system in the development of cardiovascular disease |
| Q34075171 | Therapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes |
| Q77067103 | Tissue remodelling in the adrenal gland |
| Q53631060 | Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. |
| Q35686201 | Vascular angiotensin II actions mediated by angiotensin II type 2 receptors |
Search more.